Amanta Healthcare Ltd (AMANTA) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

52.95 k (-20.75%) Volume

Shareholding (Jun 2026)

FII

0.43%

Held by 3 FIIs

DII

12.92%

Held by 2 DIIs

Promoter

63.80%

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 14.23%

Poor long term growth as Net Sales has grown by an annual rate of -2.00% and Operating profit at 9.30% over the last 5 years
High Debt Company with a Debt to Equity ratio (avg) at 2.51 times

Flat results in Mar 26

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

INR 726 Cr ()

P/E

47.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.00

Return on Equity

0.00%

Price to Book

3.46

Revenue and Profits:

Net Sales:

69 Cr

(Quarterly Results - Jun 2026)

Net Profit:

3 Cr

Total Returns

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

2.4%

6 Months

76.59%

1 Year

41.23%

2 Years

0.0%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

Amanta Healthcar for the last several years.

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

No Recent News for the Company

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

06-Oct-2026 | Source : BSE

Certificate under Reg 74(5) of SEBI (DP) Regulations 2018

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

05-Oct-2026 | Source : BSE

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Pravinchandra Mehta

Submission Of Disclosures Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations 2015 - Off Market Transfer Of Equity Shares

01-Oct-2026 | Source : BSE

Submission of Disclosures under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations 2015 - Off-Market Transfer of Equity shares

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-2.00%

EBIT Growth (5y)

9.30%

EBIT to Interest (avg)

1.89

Debt to EBITDA (avg)

3.54

Net Debt to Equity (avg)

1.99

Sales to Capital Employed (avg)

0.74

Tax Ratio

29.05%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

13.35%

ROCE (avg)

13.00%

ROE (avg)

8.18%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.46

EV to EBIT

22.42

EV to EBITDA

15.35

EV to Capital Employed

2.45

EV to Sales

3.14

PEG Ratio

Dividend Yield

ROCE (Latest)

11.06%

ROE (Latest)

7.30%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Dow Theory

Mildly Bearish

No Trend

OBV

No Trend

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Jun 2026

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 1 Schemes (5.33%)

FIIs

Held by 3 FIIs (0.43%)

Promoter with highest holding

Bhavesh Girishbhai Patel (16.31%)

Highest Public shareholder

Bandhan Small Cap Fund (5.33%)

Individual Investors Holdings

17.45%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is -10.64% vs 3.36% in Mar 2026",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is -40.14% vs 19.44% in Mar 2026",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "68.80",
          "val2": "76.99",
          "chgp": "-10.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "14.54",
          "val2": "14.95",
          "chgp": "-2.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "6.00",
          "val2": "4.25",
          "chgp": "41.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "3.31",
          "val2": "5.53",
          "chgp": "-40.14%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "21.13%",
          "val2": "19.42%",
          "chgp": "1.71%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Amanta Healthcar"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Amanta Healthcar"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 4.72% vs -2.01% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 41.71% vs 189.26% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "287.68",
          "val2": "274.71",
          "chgp": "4.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "59.86",
          "val2": "59.67",
          "chgp": "0.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "20.75",
          "val2": "27.95",
          "chgp": "-25.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.63",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "14.88",
          "val2": "10.50",
          "chgp": "41.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.81%",
          "val2": "21.72%",
          "chgp": "-0.91%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Jun'26 - QoQ

Jun'26

Mar'26

Change(%)

Net Sales

68.80

76.99

-10.64%

Operating Profit (PBDIT) excl Other Income

14.54

14.95

-2.74%

Interest

6.00

4.25

41.18%

Exceptional Items

0.00

Standalone Net Profit

3.31

5.53

-40.14%

Operating Profit Margin (Excl OI)

21.13%

19.42%

1.71%

Values in Rs Cr.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2026 is -10.64% vs 3.36% in Mar 2026

Standalone Net Profit

QoQ Growth in quarter ended Jun 2026 is -40.14% vs 19.44% in Mar 2026

All Quarterly Results

Annual Results Snapshot (Standalone) - Mar'26

Mar'26

Mar'25

Change(%)

Net Sales

287.68

274.71

4.72%

Operating Profit (PBDIT) excl Other Income

59.86

59.67

0.32%

Interest

20.75

27.95

-25.76%

Exceptional Items

-2.63

0.00

Standalone Net Profit

14.88

10.50

41.71%

Operating Profit Margin (Excl OI)

20.81%

21.72%

-0.91%

Values in Rs Cr.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2026 is 4.72% vs -2.01% in Mar 2025

Standalone Net Profit

YoY Growth in year ended Mar 2026 is 41.71% vs 189.26% in Mar 2025

All Annual Results

Company CV

About

Company Coordinates

Company Details

Tel:

Registrar Details

Name: MOJO Markets Private Limited (Research Entity) (SEBI Registration No. INH000021942) (CIN:U74900MH2015PTC264951)

Registered & Correspondence Address: Benefice Business House, Office No. 3B, 3rd Floor, C.S. 242, Mathuradas Mills Estate, N.M. Joshi Marg, Tulsi Pipe Road, Lower Parel West, Mumbai- 400013

For queries or grievances, please contact us on support.ra@mojomarkets.in, Phone : 022-35121239

"Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors."